Alright, I didn't read the paper - but I can think of a few points of criticism:
1. How long and how much did these guys take AS. Also how long have they been off? All of these variables could profoundly influence the development, activation, and/or maturation of satellite cells into myonuclei.
2. What endocrinological factors influence myonuclei development and maintainance? You may undergo hyperplasia but once you go off steroids, do you have the hormonal strength to activate the growth of that new fiber? These may be "inactive" in that natual levels of test, etc. may only be able to support a limited number of myonuclei.
3. Technical flaws. Biopsy sampling variation has plagued in vivo hyperplasia studies for decades. It's really not that easy (or accurate) to determine muscle fiber count without excising the entire muscle.
1. How long and how much did these guys take AS. Also how long have they been off? All of these variables could profoundly influence the development, activation, and/or maturation of satellite cells into myonuclei.
2. What endocrinological factors influence myonuclei development and maintainance? You may undergo hyperplasia but once you go off steroids, do you have the hormonal strength to activate the growth of that new fiber? These may be "inactive" in that natual levels of test, etc. may only be able to support a limited number of myonuclei.
3. Technical flaws. Biopsy sampling variation has plagued in vivo hyperplasia studies for decades. It's really not that easy (or accurate) to determine muscle fiber count without excising the entire muscle.